Nucleo Longevity

Calcium alpha-ketoglutarate (Ca-AKG)

Ca-AKG · calcium alpha-ketoglutarate · AKG · alpha-ketoglutarate

A Krebs-cycle intermediate promoted to lower 'biological age'.

TipoSupplement / dietary

Il voto risponde a: What does the human evidence support for: Metabolic / epigenetic aging?

Grado

C

Limitata

Il voto misura la qualità dell'evidenza, non è un consiglio ad assumere o acquistare.

Classe
Metabolic intermediate
Uso principale
Metabolic / epigenetic aging
Forza evidenza
low
Ultima revisione
2026-07-01

In sintesi

Strong animal data and one small, widely-cited human study on biological-age markers — but the human evidence is thin, early, and partly industry-linked. Interesting, far from proven.

Cosa dice l'evidenza

Alpha-ketoglutarate is a central metabolite in the Krebs cycle and a cofactor for enzymes that regulate the epigenome and collagen synthesis; its levels fall with age. In animals it extended healthspan and, in some models, lifespan. The human story rests largely on a single small study reporting a reduction in an epigenetic 'biological age' clock with a Ca-AKG formulation — promising but preliminary, unblinded in parts, and connected to the product's makers. Grade C: compelling mechanism and animal data, minimal independent human evidence.

Studi chiave

  1. [1]

    Ca-AKG and biological age markers in adults (pilot) · pilot trial

    Reported drop in an epigenetic-age clock — small, preliminary.

    Apri su PubMed
  2. [2]

    Alpha-ketoglutarate and healthspan in animals · preclinical

    Healthspan/lifespan signals in animal models.

    Apri su PubMed
  3. [3]

    Alpha-ketoglutarate metabolism and aging (review) · review

    Explains the epigenetic-cofactor rationale.

    Apri su PubMed
Vedi tutti gli studi su PubMed

Meccanismo

Serves as a Krebs-cycle intermediate and as a cofactor for dioxygenase enzymes (including TET and prolyl-hydroxylases) that influence DNA methylation, collagen synthesis and hypoxia signalling.

Sicurezza

Generally well tolerated in the limited human data; longer-term safety is not established. As a supplement it also delivers calcium, which counts toward total intake.

Contesto dosaggio

The cited human work used ~1 g/day of a Ca-AKG formulation. No independent dose-finding or replication has established an optimal regimen.

Esempi di applicazione

  • Taken as ~1 g/day of the Ca-AKG form used in the cited study.
  • Evidence rests on one small biological-age trial — treat as early.
  • Also adds calcium toward daily intake.

Nota dal campo

Ca-AKG rides on one small biological-age study and strong mouse data. We grade it C and are explicit that a single, partly self-interested human trial is a starting point, not a verdict.

Molecole correlate